Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. During cell cycle progression from the midto late G 1 phase, mammalian cells traverse the restriction point, a transition from mitogen dependence to mitogen independence, regulated by retinoblastoma protein (Rb). Different cyclin-dependent kinases (CDKs) sequentially phosphorylate and inactivate Rb, which is associated by a change in Rb's nuclear affinity and activation of E2F transcription. Here, we show by in vitro kinase assays that ALL extracts contained CDK2 catalytic activity. When liberation of Rb from cell nuclei was tested by immune precipitation of differential cell extractions and Western blot analysis, little Rb was associated with the nuclear compartment. Together with the immunocytochemical analysis at a single cell level that Rb was phosphorylated at serine 612 and threonine 821, sites known to be phosphorylated by CDK2, the data indicated the presence of CDK2 catalytic activity and loss of Rb's nuclear affinity in ALL cells. We conclude that most ALL cells reside at or beyond the restriction point. This could explain the resistance of ALL cells to differentiation induction.
Introduction
Acute lymphoblastic leukemia is the most frequent malignancy in childhood. Although treatment with chemotherapy results in a high cure rate, a substantial number of children still suffer from relapse and eventually die from disease. Leukemias exhibit both loss of normal proliferation controls and a block in completing differentiation into functional mature cells. 1 Acute lymphoblastic leukemia (ALL) cells do not respond to differentiationinducing signals. More than 80% of childhood ALL cells reside in the G 1 phase and only a few G 0 cells are present. [2] [3] [4] However, the exact position of ALL cells within the G 1 phase, before or after the restriction point, is not known.
During cell cycle progression in mammalian cells, early G 1 cells are responsive to environmental stimuli inducing differentiation. After traverse of the restriction point in the mid-to late G 1 phase, cells are committed to cell division and no longer respond to differentiation-inducing signals. 5 Retinoblastoma protein (Rb) regulates the passage of cells through the restriction point. 6 Underphosphorylated Rb has growth-suppressive properties and neutralizes transcription factors, notably members of the E2F family. 7 Functional inactivation of Rb by hyperphosphorylation requires the collaboration of at least two distinct cyclin/CDK complexes, 8, 9 such as the cyclin D/CDK4,6 and cyclin E/CDK2 complexes, and is associated with a change in Rb's nuclear affinity. 10 The shift in Rb phosphorylation from cyclin D/CDK4,6 complexes to cyclin E/CDK2 in the late G 1 phase accounts in part for the loss of dependency on extracellular signalling at the restriction point. 11 Rb phosphorylations were detected in childhood ALL extracts at cyclinD/CDK4,6-preferred sites serine (Ser) 249/252, threonine (Thr) 373, Ser 608, Ser 780, Ser 795 and Ser 807/811, 12 suggesting that phosphorylations by these early acting mid-G 1 cyclin/CDK complexes occurred in vivo in ALL cells. Hence, we wondered which set of cyclin/CDK complexes were active and contributed to childhood ALL. We determined the catalytic activities of CDK2, CDK4 and CDK6 complexes by in vitro kinase assays. Since the activity of CDK2 increases in late G 1 phase (transition to the S phase), 13 it was of special interest to test the catalytic activity of this enzyme from childhood ALL cells. Since these measurements must be interpreted in relation to the cell's proliferative characteristics, we studied cell populations with proliferation rates different from those of ALL samples. We used the rapidly dividing NALM-6 cell line derived from a human precursor B cell (PBC) ALL, growth-arrested cells of the embryonic mouse NIH3T3 fibroblast cell line and mobilized human CD34 þ hemopoietic progenitor cells, that reside mainly in the G 1 phase. Only 1-3% of mobilized CD34 þ cells are in the S/G 2 þ M phase. 3, 4, 14 In vitro kinase assays indicated that CDK2 catalytic activity was significant in childhood ALL extracts. Furthermore, much Rb was soluble and no longer associated with the nuclear compartment in ALL samples, as determined by immune precipitation of differential cell extractions. Accordingly, staining cytocentrifuge cell preparations with phosphorylation site-specific antibodies indicated that CDK2-preferred sites in Rb, Ser 612 and Thr 821, 15, 16 were phosphorylated in over 90% of ALL cells. Most ALL cells reside at or beyond the restriction point. This could explain the resistance of ALL cells to differentiation induction.
Patients, materials and methods

Cell lines and patient samples
Semiconfluent NALM-6 cells (1.5 million per ml) were grown in RPMI 1640 10% FCS (Sigma, St Louis, USA) in 5% CO 2 at 371C. NIH3T3 fibroblasts (ATCC: CCL 92) were contact-inhibited and incubated for 1 week in DMEM containing 2% FCS at 371C in 5% CO 2 to achieve quiescence. Bone marrow aspirates were from untreated children with T-cell (ALL#1) or precursor B-cell ALL (ALL#3 to ALL#11). ALL#2 was from relapsed childhood precursor B-cell ALL. Each ALL sample examined here was bone marrow derived. After Ficoll (Nycomed Pharma, Oslo, Norway) density gradient centrifugation, smears contained over 90% leukemia cells as assessed by morphology. Hemopoietic progenitor cells were collected by leukapheresis after combined mobilization treatment with chemotherapy and G-CSF. 4 This study was approved by the Institutional Review Boards of the Department of Pediatrics, University Hospitals Bern and of the Faculty of Medicine, University of Bern.
Flow cytometry
Five million cells were resuspended in 200 ml phosphate-buffered saline (PBS), then sonicated for 10 s with a Labsonic 1510 (Braun, Melsungen, Germany), and 800 ml cold ethanol was added. Cells were fixed at 41C over night. One million cells were washed and resuspended in 1 ml buffer containing 38 mM sodium citrate (pH 7.5), 50 mg/ml propidium iodide (Sigma, St Louis, USA), 1 mg/ml RNase A (Sigma) for 30 min at 371C and analyzed with a FACScan flow cytometer (Becton Dickinson, NJ, USA).
Protein extracts
Cells were resuspended in lysis buffer containing 420 mM NaCl, 50 mM Tris-HCl (pH 8.0), 1% Nondidet P-40, 10 mM b-glycerophosphate, 10 mM NaF, 2 mM sodium orthovanadate, protease inhibitor cocktail (Roche, Basel, Switzerland) and 1 mM phenylmethylsulfonyl fluoride (PMSF). After 10 passages through a 27-gauge needle, the lysate was incubated for 30 min on ice and centrifuged for 30 min at 13 000 r.p.m. at 41C. Aliquots of 40 mg were stored at À801C.
Western blotting
A total of 40 mg protein was subjected to 12% SDS-PAGE. Equal loading was controlled by Coomassie brilliant blue (Sigma, St Louis, USA) staining. Proteins were transferred to polyvinylidene difluoride (PVDF) membrane (Roche, Basel, Switzerland) in a Mini Trans Blot Cell (Bio-Rad, IL, USA) 45 min 60 V. Blots were saturated with 0.25% gelatine in Tris-buffered saline (pH 7.1) 17 30 min at room temperature (RT), washed twice for 5 min in TBST buffer (Tris-buffered saline, 0.02% gelatin, 0.12% Triton X-100 (pH 7.1)), incubated with Ab 0.5 mg/ml TBST buffer 60 min at RT, washed twice 5 min in TBST buffer at RT, and incubated with protein G-horseradish peroxidase (Zymed, CA, USA) 0.15 mg/ml in TBST buffer for 30 min at RT. Blots were washed four times in TBST buffer 15 min RT and proteins were visualized by chemiluminescence with Lumi-Light PLUS Western Blotting substrate and the Lumi-Imager F1 workstation (both from Roche, Basel, Switzerland).
Immune precipitation
Cell lysates were centrifuged for 30 min at 13 000 r.p.m. at 41C and precleared with 40 ml protein A-agarose (Roche, Basel, Switzerland) 30 min at 41C using a rotating wheel. After centrifugation of 30 min at 13 000 r.p.m. at 41C, lysates were immune precipitated with 6 mg Ab 1 h on ice. Protein aggregates were removed for 30 min at 13 000 r.p.m. 41C. Immune complexes were recovered with 40 ml protein A-agarose 1 h at 41C, washed several times with 600 ml PBS and boiled for 3 min in final sample buffer.
Antibodies
Antibodies used were as follows: Rb (sc-7905), CDK4 (sc-260), CDK6 (sc-177), CDK2 (sc-163), cyclin D1 (sc-246), cyclin D2 (sc-181), cyclin D3 (sc-182), cyclin E (sc-198), cyclin A (sc-239), Lex A (sc-1725) (Santa Cruz, CA, USA). Upstate, NY, USA: EF1A (no. 05-235). Cyclin A, Ab-6 clone CYA06 (Lab Vision Neomarkers, CA, USA). Anti-ppSer 612 Rb (Biosource International, CA, USA). Anti-ppThr 821 Rb (New England Biolabs, MA, USA).
Immunocytochemistry
Cytocentrifuge cell preparations were stained with phosphorylation site-specific antibodies to Rb in duplicate according to the alkaline phosphatase:anti-alkaline phosphatase (APAAP) method 18 and were evaluated by light microscopy. At least 1000 cells per preparation were counted.
In vitro kinase assays
Ten million cells were lysed in buffer containing 1% Nondidet P-40, 20 mM Na 2 HPO 4 (pH 7.4), 250 mM NaCl, 5 mM EDTA, 5 mM dithiothreitol (DTT), 25 mM b-glycerophosphate, 0.1 mM sodium orthovanadate, 2 mg/ml leupeptin, 1.5 mg/ml aprotinin and 1 mM PMSF. Immune precipitates obtained with 6 mg Ab 1 h on ice were coupled to 40 ml protein A-agarose (Roche, Basel, Switzerland) for 1 h at 41C, washed four times with lysis buffer, once with 100 mM Tris (pH 7.5), 0.5 M LiCl, 1 mM PMSF and once with kinase buffer (20 mM Tris (pH 7.5), 7.5 mM MgCl 2 , 1 mM DTT, 0.5 mM EGTA, 25 mM b-glycerophosphate, 0.5 mM sodium orthovanadate, 1 mM PMSF, 2 mg/ml leupeptin and 1.5 mg/ml aprotinin). Immune complexes were resuspended in 30 ml kinase buffer. To this were added 10 ml containing kinase buffer, 10 mCi [g-33 P] ATP (Amersham, Buckinghamshire, UK), 2.5 mg full-length active Rb (QED-Bioscience, CA, USA). Rb was labelled 30 min at 371C. For competition with unlabelled ATP, immobilized immune complexes were split. Substrate with or without 7 mM ATP (Amersham, Buckinghamshire, UK) was added. Reactions were boiled for 3 min in sample buffer and proteins separated by 12% SDS-PAGE. Proteins transferred to PVDF membranes were visualized by autoradiography with Biomax Scientific Imaging Film (Kodak, NY, USA). The LumiImager F1 workstation was used for densitometric analysis after scanning autoradiographies with PSC2200 (Hewlett-Packard, CA, USA). CDK2 catalytic activity was inhibited by 175 mM roscovitine: 1 ml of 14 mM roscovitine (Sigma, St Louis, USA) in the vehicle dimethyl sulfoxide (DMSO) was added to immune complexes resuspended in 30 ml kinase buffer 19 containing 20 mM ATP (Amersham, Buckinghamshire, UK).
Differential cell extractions
Ten million cells were washed with PBS, resuspended in lysis buffer (10 mM HEPES-NaOH (pH 7.9), 10 mM KCl, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.1% Triton X-100, 10 mM b-glycerophosphate, 2 mM sodium orthovanadate, 10 mM NaF, 2 mg/ml leupeptin, 1.5 mg/ml aprotinin and 1 mM PMSF), and then centrifuged for 10 min at 10 000 r.p.m. 41C (supernatant S1). The cell pellet was subjected to the same procedure until S8 was obtained and was then resuspended in the original volume of the same buffer adjusted to 250 mM NaCl. Resuspend 10 times in a glass homogenizer with a loose-fitting pestle (Roth, Karlsruhe, Germany) on ice. Supernatants were centrifuged at 13 0000 r.p.m. for 30 min at 41C.
Results
Protein levels of G 1 cyclins
The abundance of G 1 cyclins was determined in total cell lysates by Western blot analysis. Cyclin D1 was detected in 8 of 11 ALL extracts, consistent with earlier reports, 20, 21 and was expressed in all three CD34 þ cell samples. Cyclins D2, D3, E and A were detected in every extract, whereas expression was small or nondetectable in quiescent NIH3T3 cell extracts (Figure 1 ).
Proliferation characteristics
Expression of G 1 cyclins may influence the proliferation characteristics of cells. The cell cycle distribution of ALL and CD34 þ cell populations was determined by flow cytometry relative to the rapidly proliferating NALM-6 cell line. In the ALL cell populations, the mean of cells in G 1 phase was 8679% and the mean of cells in S phase was 976%. The number of G 1 cells in CD34 þ cell populations was 97.5 and 93.8%. Values for CD34 þ cells in S phase were 2.3 and 5.6%, consistent with our previous studies, 3, 4 whereas in cell populations of the NALM-6 cell line, the mean of cells in the G 1 phase was 4078% and the mean of cells in S phase was 4475% (Supplementary Figure 1) . We have shown previously that most childhood ALL (480%) and mobilized CD34 þ cells (490%) resided in the G 1 phase and only a few resting G 0 cells were present. [2] [3] [4] Therefore, ALL and CD34 þ cells seem to have comparable proliferation characteristics, bearing in mind that their genetic background is different.
Activity of cyclin-dependent kinases
To test their catalytic activity, immune precipitates, obtained with anti-CDK2, anti-CDK4 or anti-CDK6 antibody, were subjected to in vitro kinase assays, Western blotting and autoradiography. First, specific phosphorylation of Rb was tested. Rb labelling with CDK immune precipitates from NALM-6 cells was inhibited with unlabelled ATP (Figure 2a) . When CDK2 immune precipitates were tested for kinase activity, Rb labelling was most efficient with NALM-6 and ALL extracts (Figure 2b ). Testing kinase activity in CDK4 or CDK6 immune precipitates indicated that Rb labelling varied among ALL extracts, and was efficient with CD34 þ extracts (Figure 2b ). When the catalytic activity in CDK2 immune precipitates from extracts of NALM-6 cells, CD34 þ cells or ALL cells was inhibited with roscovitine, Rb labelling was inefficient (Figure 3 , lane 3) compared to labelling without IgGs ( Figure 3, lane 1) . Since the addition of vehicle alone was without significant effect ( Figure 3 , lane 4), roscovitine specifically inhibited CDK2 catalytic activity.
Detection of phosphorylated Rb in cytocentrifuge cell preparations
To examine whether Rb was phosphorylated at CDK2 preferred sites in ALL cells, cytocentrifuge cell preparations of 20 ALL cell samples were stained with specific antibodies against phosphorylated (pp)Ser 612 or ppThr 821, two sites in Rb known to be phosphorylated by CDK2. The mean of positive cells was 9275% with anti-ppSer 612 antibody and 9376% with antippThr 821 antibody. In contrast, less than 1% positive cells were detected with each antibody in cytocentrifuge cell preparations of CD34 þ cells.
Analysis of Rb's nuclear affinity
To examine Rb's ability to bind nuclear structures, liberation of Rb from cell nuclei was tested with buffer of low ionic strength. Extracts were immune precipitated and immunoblotted with anti-Rb antibody. First, NALM-6 cells were tested and Rb was liberated from the cell nuclei in hypotonic buffer (Figure 4a , lane S1). After repeated cell extractions with hypotonic buffer, less Rb was liberated (Figure 4a, lanes S2-S8) . Next, the cell pellet was resuspended in high ionic strength buffer and much Rb was liberated that was insoluble in hypotonic buffer ( Figure 4a , lane P). Thus, NALM-6 cells contained a mix of tethered and soluble forms of Rb. When immune precipitates of Rb were obtained from low ionic strength extracts of quiescent NIH3T3 cells or CD34 þ cells for Western blot analysis with anti-Rb antibody, liberation of Rb from cell nuclei was not observed (Figure 4b, lane S) . Rb was only immune precipitated from the high-salt eluate of NIH3T3 or CD34 þ cell pellets ( Figure 4b, lane P) . Analysis of low ionic strength extracts (S1) from ALL samples indicated that each lysate contained much Rb liberated from cell nuclei (Figure 4b, lanes S) . When high ionic strength extracts from ALL cell pellets were tested, 7 of 11 extracts contained Rb ( Figure 4b , lanes P).
Discussion
Cell cycle analysis revealed that most childhood ALL cells reside in the G 1 phase, only a few cells are in the G 0 phase. [2] [3] [4] However, cells do not respond to differentiation-inducing signals. It was important to determine whether ALL cells reside before or after the restriction point. Compared to the significant G 1 compartment of ALL cell populations, the proportion of cells in S, G 2 and M phases is small. Therefore, at clinical diagnosis, the proliferation rate of ALL cells is not high, but the loss of differentiation and the lack of apoptosis cause a continuous accumulation of malignant cells. 22 Mammalian cells respond to differentiation-inducing stimuli only in the early G 1 phase. Passage of the restriction point in the mid to late G 1 phase results in sequential phosphorylation of Rb by cyclin D/CDK4,6 and cyclin E/CDK2, which is associated with a change in Rb's nuclear affinity, 10 inactivation of Rb's growth suppressor function 8, 9 and activation of E2F transcription. Whereas Rb phosphorylated by cyclin D/CDK4,6 might still be tethered to the nuclear matrix, further phosphorylation by CDK2 decreases Rb's nuclear affinity and Rb can be liberated from cell nuclei by buffers of low ionic strength. We determined more precisely the position of ALL cells within the G 1 phase. The catalytic activities of G 1 cyclin/CDK complexes were tested and Rb phosphorylation of CDK2-preferred sites in ALL cells was analyzed by immunocytochemistry at a single cell level. Furthermore, Rb's nuclear affinity was examined by immune precipitations of differential cell extractions and Western blot analysis. Since these parameters are cell cycle dependent, ALL cells were compared with cell systems of distinct proliferative characteristics, bearing in mind that their genetic information is different.
Previously, Western blot analysis of ALL extracts indicated that Rb was phosphorylated at CDK4,6-specific phosphoacceptor sites. 12 The catalytic activities of CDK4 and CDK6 complexes varied among ALL extracts. Different explanations can be discussed. The differential expression of cyclins D1, D2 and D3 indicated that the concentration of D-type cyclins, available for binding to CDK4 and CDK6 catalytic subunits, varied between ALL samples. Furthermore, the results raised the issue of whether cell cycle progression advanced beyond the execution points of cyclin D/CDK4,6 activities in G 1 cells of ALL samples or, if Rb were not completely dephosphorylated after mitosis, CDK4,6 activities might not be critical for Rb phosphorylation. In contrast to CDK4,6 activities, CDK2 catalytic activity was clearly detected in every ALL sample investigated. The presence of CDK2 catalytic activity was consistent with phosphorylation of Ser 612 and Thr 821 in Rb and the significant loss of Rb's nuclear tethering in ALL samples. In contrast, extracts of quiescent NIH3T3 cells lacked any CDK activity and contained only tethered Rb. Similar to ALL cells, NALM-6 cells contained significant CDK2 catalytic activity and most Rb lost nuclear affinity, although, the mean of G 1 cells from the rapidly dividing NALM-6 cell line was 4078% and the mean of cells in the S phase was 4475%. Compared to ALL extracts, the autoradiographic signal derived from CDK2 catalytic activity of CD34 þ extracts was faint. The corresponding CDK2-preferred sites Ser 612 and Thr 821 were not phosphorylated in CD34 þ cells and soluble Rb was not detected, suggesting that CDK activities in CD34 þ extracts did not alter Rb's nuclear affinity, consistent with the reported underphosphorylated status of Rb in CD34 þ cells. 4 The differences between childhood ALL and CD34 þ hemopoietic progenitor cell samples suggested a different position of cells within the G 1 phase. These findings indicated a position of ALL cells at or beyond the restriction point. Much Rb may be functionally inactivated in ALL cells due to the loss of nuclear affinity, suggesting that E2F transcription was activated and promoted mitogen independence. Since differentiation is initiated only from early G 1 phase, 23 the resistance of ALL cells to differentiation-inducing agents could be explained by their position at or beyond the restriction point. On the other hand, the majority of CD34 þ cells could reside in early G 1 phase before the restriction point, consistent with evidence that CD34 þ cells fully respond to differentiation-inducing stimuli from the environment.
In summary, CDK2 catalytic activity was present in childhood ALL samples and Rb was phosphorylated at the corresponding phosphoacceptor sites. Moreover, much Rb lost binding to the nuclear compartment and therefore, the growth suppressor function of this soluble Rb was inactivated. The results suggested that CDK2 contributed to the functional inactivation of Rb complexes in ALL samples. ALL cells may reside at or beyond the restriction point. In this cell cycle position, E2F transcription could be activated and could promote mitogen independence, thereby rendering ALL cells resistant to differentiation-inducing signals. Future studies will help to determine whether ALL cells can be blocked in vivo in early G 1 phase before activation of CDK2 protein kinase, and whether this block would render ALL cells susceptible to differentiation in vitro and differentiationinduction therapy.
